(VIANEWS) - Coda Octopus Group (CODA), Omnicell (OMCL), Dow Chemical Company (DOW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Coda Octopus Group (CODA)
34.7% sales growth and 15.86% return on equity
Coda Octopus Group, Inc., together with its subsidiaries, develops and sells underwater technologies and equipment for imaging, mapping, defense, and survey applications in the Americas, Europe, Australia, Asia, the Middle East, and Africa.
Coda Octopus Group's sales growth this year is expected to be 12.4% and 28.3% for next year.
Year-on-year quarterly revenue growth grew by 63.4%, now sitting on 20.5M for the twelve trailing months.
Volume
Today's last reported volume for Coda Octopus Group is 3396 which is 83.35% below its average volume of 20392.
Coda Octopus Group's sales growth is a negative 0% for the present quarter and 34.7% for the next. The company's growth estimates for the present quarter and the next is 33.3% and 27.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.86%.
Volatility
Coda Octopus Group's last day, last week, and last month's current volatility was 1.30%, 2.99%, and 2.10%, respectively.
Coda Octopus Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.15% (day), 4.60% (last week), and 4.45% (last month), respectively.
Coda Octopus Group's Stock Yearly Top and Bottom Value
Coda Octopus Group's stock is valued at $8.96 at 23:22 EST, way below its 52-week high of $10.17 and way above its 52-week low of $4.91.
Coda Octopus Group's Moving Average
Coda Octopus Group's value is higher than its 50-day moving average of $8.89 and way higher than its 200-day moving average of $7.97.2. Omnicell (OMCL)
30.4% sales growth and 3.71% return on equity
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
Omnicell's sales growth this year is expected to be 23.5% and 13.2% for next year.
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 914.36M for the twelve trailing months.
Volume
Today's last reported volume for Omnicell is 51395 which is 78.83% below its average volume of 242804.
Omnicell's sales growth for the next quarter is 30.4%. The company's growth estimates for the present quarter and the next is 121.6% and 53.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.71%.
Volatility
Omnicell's last day, last week, and last month's current volatility was 0.17%, 0.89%, and 1.52%, respectively.
Omnicell's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.73% (day), 2.05% (last week), and 3.43% (last month), respectively.
Omnicell's Stock Yearly Top and Bottom Value
Omnicell's stock is valued at $152.08 at 23:22 EST, below its 52-week high of $154.92 and way higher than its 52-week low of $65.21.
Omnicell's Moving Average
Omnicell's value is above its 50-day moving average of $145.85 and way above its 200-day moving average of $134.63.3. Dow Chemical Company (DOW)
29.5% sales growth and 14.57% return on equity
Dow Inc. provides various materials science solutions for consumer care, infrastructure, and packaging markets in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and Latin America.
Dow Chemical Company's sales growth this year is anticipated to be 27% and 0.5% for next year.
Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 40.65B for the twelve trailing months.
Volume
Today's last reported volume for Dow Chemical Company is 6895310 which is 56.77% above its average volume of 4398380.
Dow Chemical Company's sales growth for the next quarter is 29.5%. The company's growth estimates for the current quarter and the next is 961.5% and 274%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.57%.
Volatility
Dow Chemical Company's last day, last week, and last month's current volatility was 0.66%, 1.01%, and 1.08%, respectively.
Dow Chemical Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.67% (day), 2.28% (last week), and 2.21% (last month), respectively.
Dow Chemical Company's Stock Yearly Top and Bottom Value
Dow Chemical Company's stock is valued at $60.01 at 23:22 EST, way below its 52-week high of $71.38 and way higher than its 52-week low of $39.90.
Dow Chemical Company's Moving Average
Dow Chemical Company's worth is below its 50-day moving average of $65.21 and below its 200-day moving average of $62.72.4. Medical Properties Trust (MPW)
15.3% sales growth and 6.82% return on equity
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.
Medical Properties Trust's sales growth this year is expected to be 20% and 7.3% for next year.
Year-on-year quarterly revenue growth grew by 24%, now sitting on 1.34B for the twelve trailing months.
Volume
Today's last reported volume for Medical Properties Trust is 3404690 which is 23.89% below its average volume of 4473510.
Medical Properties Trust's sales growth for the next quarter is 15.3%. The company's growth estimates for the present quarter and the next is 33.3% and 24%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.82%.
Volatility
Medical Properties Trust's last day, last week, and last month's current volatility was 1.28%, 0.59%, and 0.96%, respectively.
Medical Properties Trust's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.19% (day), 1.58% (last week), and 1.98% (last month), respectively.
Medical Properties Trust's Stock Yearly Top and Bottom Value
Medical Properties Trust's stock is valued at $20.27 at 23:22 EST, way under its 52-week high of $22.82 and way above its 52-week low of $16.10.
Medical Properties Trust's Moving Average
Medical Properties Trust's value is below its 50-day moving average of $20.83 and under its 200-day moving average of $21.39.5. IEC Electronics (IEC)
12% sales growth and 13.97% return on equity
IEC Electronics Corp., together with its subsidiaries, provides electronic manufacturing services in the United States.
IEC Electronics's sales growth this year is anticipated to be 10.6% and 12% for next year.
Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 186.65M for the twelve trailing months.
Volume
Today's last reported volume for IEC Electronics is 48224 which is 18.65% below its average volume of 59280.
IEC Electronics's sales growth is a negative 0% for the ongoing quarter and 12% for the next. The company's growth estimates for the ongoing quarter and the next is 5% and 16.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.97%.
Volatility
IEC Electronics's last day, last week, and last month's current volatility was 1.54%, 1.80%, and 1.88%, respectively.
IEC Electronics's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.33% (day), 3.20% (last week), and 3.10% (last month), respectively.
IEC Electronics's Stock Yearly Top and Bottom Value
IEC Electronics's stock is valued at $10.20 at 23:22 EST, way under its 52-week high of $17.98 and way above its 52-week low of $8.30.
IEC Electronics's Moving Average
IEC Electronics's worth is under its 50-day moving average of $10.70 and way below its 200-day moving average of $12.43.6. ADTRAN (ADTN)
11.8% sales growth and 3.61% return on equity
ADTRAN, Inc. provides networking and communications equipment for service providers, cable/multiple system operators, and distributed enterprises in the United States and internationally.
ADTRAN's sales growth this year is expected to be 10.4% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 519.52M for the twelve trailing months.
Volume
Today's last reported volume for ADTRAN is 32580 which is 85.05% below its average volume of 217961.
ADTRAN's sales growth for the next quarter is 11.8%. The company's growth estimates for the current quarter and the next is 200% and 6.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.61%.
Volatility
ADTRAN's last day, last week, and last month's current volatility was 0.10%, 1.79%, and 2.70%, respectively.
ADTRAN's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.74% (day), 3.72% (last week), and 4.42% (last month), respectively.
ADTRAN's Stock Yearly Top and Bottom Value
ADTRAN's stock is valued at $19.39 at 23:22 EST, way below its 52-week high of $22.31 and way higher than its 52-week low of $9.66.
ADTRAN's Moving Average
ADTRAN's value is below its 50-day moving average of $20.50 and higher than its 200-day moving average of $18.13.7. Horizon Technology Finance Corporation (HRZN)
11.2% sales growth and 6.37% return on equity
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments.
Horizon Technology Finance Corporation's sales growth this year is anticipated to be 13.2% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 30.7%, now sitting on 49.14M for the twelve trailing months.
Volume
Today's last reported volume for Horizon Technology Finance Corporation is 96460 which is 44.52% below its average volume of 173853.
Horizon Technology Finance Corporation's sales growth for the next quarter is 11.2%. The company's growth estimates for the present quarter and the next is a negative 25% and negative -5.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.37%.
Horizon Technology Finance Corporation's Stock Yearly Top and Bottom Value
Horizon Technology Finance Corporation's stock is valued at $17.58 at 23:22 EST, under its 52-week high of $17.95 and way higher than its 52-week low of $11.03.